Drug aims to keep kidney patients out of the hospital

NCT ID NCT05347693

Summary

This study tested whether continuing a potassium-lowering medication called SZC after hospital discharge helps people with chronic kidney disease better maintain safe potassium levels compared to standard care. It involved about 186 adults who were hospitalized for high potassium. The main goal was to see if staying on the drug for 6 months after leaving the hospital reduced the risk of potassium-related problems and future hospital or emergency room visits.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Bonheiden, 2820, Belgium

  • Research Site

    Leuven, 3000, Belgium

  • Research Site

    Annonay, 07103, France

  • Research Site

    Ars-Laquenexy, 57530, France

  • Research Site

    Nice, 06000, France

  • Research Site

    Saint-Priest-en-Jarez, 42270, France

  • Research Site

    Bari, 70120, Italy

  • Research Site

    Foggia, 71122, Italy

  • Research Site

    Parma, 43125, Italy

  • Research Site

    Pavia, 27100, Italy

  • Research Site

    Eindhoven, 5602 ZA, Netherlands

  • Research Site

    Algeciras, 11207, Spain

  • Research Site

    Almería, 04009, Spain

  • Research Site

    Badajoz, 06080, Spain

  • Research Site

    Barcelona, 08907, Spain

  • Research Site

    Burgos, 9006, Spain

  • Research Site

    Getafe, 28905, Spain

  • Research Site

    Madrid, 28007, Spain

  • Research Site

    Madrid, 28040, Spain

  • Research Site

    Salamanca, 37007, Spain

  • Research Site

    San Sebastián de los Reyes, 28702, Spain

  • Research Site

    Seville, 41009, Spain

  • Research Site

    Talavera de la Reina, 45600, Spain

  • Research Site

    Zamora, 49022, Spain

  • Research Site

    Doncaster, DN2 5LT, United Kingdom

  • Research Site

    Hull, HU10 7AZ, United Kingdom

  • Research Site

    Salford, M6 8HD, United Kingdom

  • Research Site

    Stevenage, SG1 4AB, United Kingdom

Conditions

Explore the condition pages connected to this study.